![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Alcaide C. and Sumpaico W. (1989) Ulceroprotective but uterotonic. Philippine Surgery Journal, 22, 12 — 15.
- Amant F., Spitz B., Timmerman D., Corremans A. and Van Assche F. (1999) Misoprostol compared with methylergome-trine for the prevention of postpartum haemorrhage: a double-blind randomised trial. British Journal of Obstetrics and Gynaecology, 106, 1066—1070.
- Cunningham F., McDonald P., Leveno K., Gant N. and Gilstrap L. (Eds) (1993) Abnormalities of the third stage of labor. In: Williams Obstetrics, 19th edn, pp. 615–625.
- New Jersey, Prentice Hall, Appleton and Lange. de Groot A., Van Roosmalen J., Van Donger W. and Borm G. (1996) A placebo controlled trial of oral ergometrine to reduce haemorrhage. Acta Obstetricia et Gynecologica Scandinavica, 75, 464–468.
- El Refaey H. and Jauniaux E. (1997) Methods of induction of labour. Current Opinion in Obstetrics and Gynecology, 9, 375— 378.
- El-Refaey H., Nooh R., O'Brien P., Abdalla M., Geary M., Walder, J. and Rodeck C. (2000) The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. British Journal of Obstetrics and Gynaecology, 107, 1104–1110.
- Fletcher H., Mitchell S., Frederick J., Simeon D. and Brown D. (1993) Intravaginal misoprostol as a cervical ripening agent: a double-blind clinical trial. British Journal of Obstetrics and Gynaecology, 100, 641 — 644.
- Fletcher H. and Hutchinson S. (2001) A retrospective review of pregnancy outcome after misoprostol (prostaglandin El) induction of labour. West Indian Medical Journal, 50, 47 — 49.
- Hofmeyr G., Nickodem V., de Jager M. and Gelbart B. (1998) A randomised placebo controlled trial of oral misoprostol in the third stage of labour. British Journal of Obstetrics and Gynaecology, 105, 971–975.
- Huff R.W. (1987) Haemorrhage. In: Clinical Obstetetrics, edited by Pauerstein C.J., chapter 47, pp. 923–941. New York, John Wiley and Sons.
- Karim S., Trussell R., Patel R. and Hillier K. (1968) Response of pregnant uterus to prostaglandin F2a—induction of labour. British Medical Journal, 4, 621— 623.
- Keirse M.J.N.C., Noort W. and Erwick J.J.H.M. (1987) The role of prostaglandins and HJ prostaglandin synthesis in the pregnant uterus. In: Priming and Induction of Labour by Prostaglandins. 'A state of the Art', edited by Keirse M.J.N.C. & de Koning Grans, pp. 1–25. Leiden, Boerhaave Commit-tee for Post Academic Medical Education.
- McKenzie I. (1990) The therapeutic role of prostaglandins in obstetrics. In: Progress in Obstetrics and Gynaecology, edited by Studd J., vol 8, pp. 149–173. Edinburgh, Churchill Livingstone.
- Moir D. and Amoa A. (1979) Ergometrine or oxytocin? Blood loss and side effects at spontaneous vertex delivery. British Journal of Anaesthetics, 51, 113— 117.
- O'Brien P., El-Refaey H., Gordon A., Greary M. and Rodeck C. (1998) Rectally administered misoprostol for the treat-ment of haemorrhage unresponsive to oxytocin and ergome-trine. Obstetrics and Gynecology, 92, 212–214.
- Prendiville W., Harding J., Elbourne D. and Stirrat G. (1988) The Bristol third stage trial: active versus physiological management of the third stage of labour. British Medical Journal, 297, 1295–1300.
- Sanchez-Ramos L., Kaunitz A., Del Valle G., Delke I., Schroeder P. and Briones D. (1993) Labour induction with the prostaglandin El methyl analogue (Mmsoprostol) versus oxytocin: a randomised trial. Obstetrics and Gynecology, 81, 332— 336.
- Takagi S., Yoshida T., Togo Y., Togichi H., Abe M., Sakata H., Fujii T.K., Takahashi H. and Tochigi B. (1976) The effects of intramyometrial injection of prostaglandin F2 on severe haemorrhage. Prostaglandins, 12, 565–579.
- Wing D., Rahall A., Jones M., Goodwin TM., Paul R. (1995) Misoprostol: an effective agent for cervical ripening and labour induction. American Journal of Obstetrics and Gynecology, 172, 1811–1816.
- Zieman M., Fong S., Benowitz N., Bankster D. and Darney P. (1997) Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics and Gynecology, 90, 88–92.